Signal52

FOLD

NEUTRALM&A

Amicus Therapeutics, Inc.

Price
$14.28
+0.07%
Score6.0Priority
Signals5/8 DNA1/13 Act · 0/4 Risk
SentimentNEUTRALScore: 6
Volume0.6xvs 20d avg

Analysis

FOLD is currently a 'Special Situation' Merger Arbitrage play following the Dec 19, 2025 announcement of its acquisition by BioMarin (BMRN) for $4.8B (~$15.33/share). The stock is trading at $14.28, offering a ~7% gross spread, which explains the 'Quiet Storm' signal (price pinning) and 'Perfect Stack' (trend alignment) amidst the broader market volatility. The 'Alpha Male' signal reflects defensive relative strength: while the AI/Tech sector deleverages on Alphabet's Capex shock, institutional capital is hiding in this deal's hard catalyst floor.

Fired Signals

ALPHA MALEQUIET STORMGOLDEN CROSSBOLLINGER SQUEEZEPERFECT STACKSELLER FATIGUE
© 2026 Signal52 • For educational purposes only